Published July 19, 1976 | Version v1
Journal article

Plutonium controversy

Creators

  • 1. Univ. of California, Berkeley

Description

If the world chooses to seek a solution to the energy dilemma through nuclear energy, the element plutonium will become an article of commerce to be handled in quantities of thousands of tonnes annually. Plutonium is a uniquely potent inhalation carcinogen, the potential induction of lung cancer dwarfing other possible toxic effects. For reasons to be presented here, it is the author's opinion that plutonium's carcinogenicity has been very seriously underestimated. If one couples the corrected carcinogenicity with the probable degree of industrial containment of the plutonium, it appears that the commercialization of a plutonium-based energy economy is not an acceptable option for society. Sagan's statement that ''the experience of 30 years supports the contention that plutonium can be used safely'' is manifestly indefensible. No meaningful epidemiological study of plutonium-exposed workers for that 30-year period has ever been done. Since thousands of those possibly exposed have left the industry and are not even available to follow-up, it is doubtful that any meaningful study of ''the experience of 30 years'' will ever be accomplished

Additional details

Publishing Information

Journal Title
JAMA: The Journal of the American Medical Association
Journal Volume
236
Journal Issue
3
Series
J. Am. Med. Assoc.
Journal Page Range
284
ISSN
0098-7484

Optional Information

Notes
Updated automatically by Metadata and Full-Text Enrichment Agent